| Ms Mary Ann Edwards, MS/CCC-SLP | |
|
2600 Algoma Ter, Waukesha, WI 53188-4634 | |
| (262) 544-5053 | |
| Not Available |
| Full Name | Ms Mary Ann Edwards |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2600 Algoma Ter, Waukesha, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013285030 | NPI | - | NPPES |
| 42624400 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 457-154 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Mary Ann Edwards, MS/CCC-SLP 912 N. Hawley, Milwaukee, WI 53213 Ph: (414) 615-0160 | Ms Mary Ann Edwards, MS/CCC-SLP 2600 Algoma Ter, Waukesha, WI 53188-4634 Ph: (262) 544-5053 |
News Archive
A team of plastic surgeons and material scientists has made an important advance in treating the common clinical problem of soft tissue loss.
The Newcastle University team plans to use stem cells from cloned embryos to treat diabetes. The pending decision could potentially open up new possibilities for the treatment of incurable diseases, as well as dividing the British scientific community as many believe therapeutic cloning to be unethical.
Despite the numerous challenges associated with the application of nanotechnology in neuroscience, it promises to have a significant impact on our understanding of how the nervous system works, how it fails in disease, and the development of earlier and less-invasive diagnostic procedures so we can intervene in the pre-clinical stage of neurological disease before extensive neurological damage has taken place.
Idera Pharmaceuticals, Inc. today announced that it will be presenting data from preclinical studies of its Toll-like receptor (TLR) inhibitor, IMO-8400, in models of systemic lupus erythematosus (SLE) and psoriasis, which suggest that IMO-8400 may be useful for the treatment of both indications.
Working in the lab for the last few years, three generations of University of Akron polymer scientists say their mutual and passionate curiosity about science has led to their discovery of a first-of-its-kind, easily adaptable biocompatible polymer structure able to fight infection, filter water and perform a host of other functions.
› Verified 1 days ago
Katharine Lynn Starmer, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1810 Kensington Dr, Waukesha, WI 53188 Phone: 262-832-0349 | |
Katherine A Schiele, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2428 N Grandview Blvd Ste 103, Waukesha, WI 53188 Phone: 262-305-1848 | |
Brooke Michele Hooyman, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1810 Kensington Dr, Waukesha, WI 53188 Phone: 262-548-1400 | |
Mrs. Laurie Ann Gregory, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 514 Riverview Ave, Waukesha, WI 53188 Phone: 262-391-3112 | |
Jenna Mahaffey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 Carriage Dr, Waukesha, WI 53188 Phone: 608-332-9681 | |
Kayla Post, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1451 Cleveland Ave, Waukesha, WI 53186 Phone: 262-547-2123 |